Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2004 Aug 24;91(7):1391–1398. doi: 10.1038/sj.bjc.6602109

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2004 Cancer Research UK

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Expression of VEGFR2 by human tumour xenografts. (A) Western blot analysis of VEGFR2 in tumour extracts. The amount of protein analysed for PC3=120 μg, A375P=200 μg, HCT116=180 μg, HT29=200 μg, and HN5=200 μg. (B) Expression of VEGFR2 by human tumour xenografts. FACS analysis of VEGFR2 expression in PC3, SW620, A375P, HN5, HCT116, and HT29 tumours dissociated as single-cell suspensions. The fluorescence profiles of cells treated with VEGFR2 antibody (solid line) and isotype controls (dotted line).